`

Gracell Biotechnologies

Biotechnology Research

Specialities :
Car-t and cell therapy
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$100.0M
size-icon Size
11 - 50

Frequently Asked Questions About Gracell Biotechnologies

What does Gracell biotechnologies do?+

As a member of the AstraZeneca Group, Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing novel autologous and allogeneic cell therapies for cancer and autoimmune diseases. Since its inception, Gracell has established a solid inhouse R&D system. Leveraging its proprietary FasTCAR and TruUCAR technology platforms and SMART CARTTM technology modules, Gracell is researching new ways to address current challenges with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal T cell quality and barriers that limit their activity in solid tumors and autoimmune diseases

What are Gracell biotechnologies's specialties? +

Car-t and cell therapy

What is Gracell biotechnologies's industry? +

Gracell biotechnologies operates in the Biotechnology research industry.

What is Gracell biotechnologies's revenue? +

Gracell biotechnologies's revenue is 11m - 100m

What is Gracell biotechnologies's company size? +

Gracell biotechnologies has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.